All Stories

  1. Author Reply
  2. Authors' reply
  3. Author Reply
  4. Author response
  5. Effect of Targeted Aspirin Administration Based on First Trimester Combined Screening for Preeclampsia on Preterm Birth: An Interrupted Time Series Analysis
  6. Cardiac dysfunction during adverse maternal outcomes in hypertensive disorders of pregnancy
  7. ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction
  8. Impact of hypertensive disorders on disease progression in pregnancies affected by early‐onset fetal growth restriction
  9. Ambulatory foetal ECG monitoring in low and high-risk pregnancies (AMBER2): a prospective cohort study protocol
  10. Delphi consensus definition of fetal growth restriction after 8 years: implementation and future directions
  11. Translatable in‐vivo investigation of effects of progressive hypoxia in pregnancy on fetal cardiac structure and function in sheep
  12. Assessing the Clinical Effectiveness of the TRUFFLE Monitoring Protocol for Early-Onset Fetal Growth Restriction: a Retrospective Cohort Study.
  13. Foetal Cardiac Function in Early Labour and Intrapartum Outcomes: A Prospective Observational Study
  14. Predicting Adverse Perinatal Outcomes in Dichorionic Twin Pregnancies: A Multicentre Cohort Study
  15. The Impact of Dating Twin Pregnancy by the Larger, Smaller or Mean Twin Crown‐Rump Length: A Retrospective Cohort Study
  16. CARDIAC DYSFUNCTION DURING ADVERSE MATERNAL OUTCOMES IN HYPERTENSIVE DISORDERS OF PREGNANCY
  17. Comparison of glycosylated fibronectin versus soluble fms-like tyrosine kinase/placental growth factor ratio testing for the assessment of pre-eclampsia: protocol for a multicentre diagnostic test accuracy study
  18. Point‐of‐Care Tests for Preeclampsia: Systematic Review and Meta‐Analysis of Diagnostic Test Accuracy Studies
  19. Postnatal outcome of fetal cortical malformations: systematic review
  20. Cardiovascular Adaptation in Fetal Growth Restriction: A Longitudinal Study From Fetuses at Term to the First Year of Life
  21. TWIN PREGNANCY OUTCOMES WHEN DATING BY THE LARGER, SMALLER OR MEAN TWIN CROWN-RUMP LENGTH: A COHORT STUDY
  22. Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes
  23. Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation
  24. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction
  25. Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy
  26. Routine first‐trimester pre‐eclampsia screening and maternal left ventricular geometry
  27. Postpartum cardiovascular function in patients with hypertensive disorders of pregnancy: a longitudinal study
  28. Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum
  29. Correlation of short‐term variation derived from novel ambulatory fetal electrocardiography monitor with computerized cardiotocography
  30. Phase‐rectified signal averaging: correlation between two monitors and relationship with short‐term variation of fetal heart rate
  31. The significance of meeting Dawes–Redman criteria in computerised antenatal fetal heart rate assessment
  32. Is mid‐gestational uterine artery Doppler still useful in a setting with routine first‐trimester pre‐eclampsia screening? A cohort study
  33. Pan-Genomic Regulation of Gene Expression in Normal and Pathological Human Placentas
  34. Peripartum and Long-Term Maternal Cardiovascular Health After Preeclampsia
  35. Authors' reply re: The dangers of biological essentialism in addressing birth equity
  36. Routine first‐trimester pre‐eclampsia screening and risk of preterm birth
  37. Placental dysfunction screening and perinatal loss
  38. Pregnant women having a small for gestational age fetus present lower cardiac contractility
  39. Maternal echocardiographic changes in twin pregnancies with and without pre‐eclampsia
  40. Understanding maternal postnatal blood pressure changes following hypertensive disorders in pregnancy: protocol for a prospective cohort study
  41. Reducing health inequality in Black, Asian and other minority ethnic pregnant women: impact of first trimester combined screening for placental dysfunction on perinatal mortality
  42. Peripartum echocardiographic changes in women with hypertensive disorders of pregnancy
  43. Myocardial Mechanics in Hypertensive Disorders of Pregnancy: a Systematic Review and Meta-Analysis
  44. SARS-CoV-2 related myocardial injury might explain the predisposition to preeclampsia with maternal SARS-CoV-2 infection
  45. The placenta and preeclampsia: villain or victim?
  46. Effect of routine first‐trimester combined screening for pre‐eclampsia on small‐for‐gestational‐age birth: secondary interrupted time series analysis
  47. Re: ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis
  48. Placenta Accreta Spectrum Disorders and Cesarean Scar Pregnancy Screening: Are we Asking the Right Questions?
  49. Urgent neonatal balloon atrial septostomy in simple transposition of the great arteries: predictive value of fetal cardiac parameters
  50. Preeclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?
  51. The association between a shared placenta and pregnancy outcome in triplet pregnancies
  52. Time to reconsider elective Cesarean birth
  53. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low‐lying placenta and previous uterine surgery
  54. Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre‐eclampsia: a systematic review and meta‐analysis
  55. Reduction in twin stillbirth following implementation of NICE guidance
  56. Performance of Antenatal Diagnostic Criteria of Twin-Anemia-Polycythemia Sequence
  57. Non‐immune fetal hydrops: etiology and outcome according to gestational age at diagnosis
  58. The Association Between Hypertension in Pregnancy and Preterm Birth with Fetal Growth Restriction in Singleton and Twin Pregnancy: Use of Twin Versus Singleton Charts
  59. Maternal Cardiac Dysfunction Precedes Development of Preeclampsia
  60. Implementation of routine first trimester combined screening for pre‐eclampsia: a clinical effectiveness study
  61. Post-Laser Twin Anemia Polycythemia Sequence: Diagnosis, Management, and Outcome in an International Cohort of 164 Cases
  62. Selective Fetal Growth Restriction in Dichorionic Twin Pregnancies: Diagnosis, Natural History, and Perinatal Outcome
  63. Speckle Tracking Echocardiography: New Ways of Translational Approaches in Preeclampsia to Detect Cardiovascular Dysfunction
  64. Evidence for uteroplacental malperfusion in fetuses with major congenital heart defects
  65. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study
  66. Diagnosis of fetal abnormalities using exome sequencing: translating research into practice
  67. Cesarean Scar Pregnancy Registry: an international research platform
  68. Ductus venosus Doppler waveform pattern in fetuses with early growth restriction
  69. The impact of gestational diabetes on maternal cardiac adaptation to pregnancy
  70. Maternal cardiovascular function and risk of intrapartum fetal compromise in women undergoing induction of labor: a pilot study
  71. Maternal arterial stiffness in hypertensive pregnancies with and without a small‐for‐gestational‐age neonate
  72. Consensus diagnostic criteria and monitoring of twin anemia polycythemia sequence: a Delphi procedure
  73. Influence of maternal characteristics and gestational age on hemodynamic indices: NICOM device‐specific reference ranges
  74. Cardiac maladaptation in obese pregnant women at term
  75. Early and late selective fetal growth restriction in monochorionic diamniotic twin pregnancies: natural history and diagnostic criteria
  76. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small‐for‐gestational‐age fetus?
  77. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function
  78. Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study
  79. Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts
  80. Comparative analysis of the 2‐year outcomes in the GRIT and TRUFFLE trials
  81. Left ventricular torsional mechanics in term fetuses and neonates
  82. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
  83. Long‐term neuroimaging and neurological outcome of fetal spina bifida aperta after postnatal surgical repair
  84. Prediction of adverse pregnancy outcome in monochorionic diamniotic twin pregnancy complicated by selective fetal growth restriction
  85. Risk of operative delivery for intrapartum fetal compromise in small-for-gestational-age fetuses at term: external validation of the IRIS algorithm
  86. Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction according to management: systematic review and meta‐analysis
  87. Selective fetal growth restriction in monochorionic twin pregnancy: a dilemma for clinicians and a challenge for researchers
  88. Longitudinal change in the cerebroplacental ratio and the risk of stillbirth
  89. Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta‐analysis
  90. Perinatal changes in fetal cardiac geometry and function in gestational diabetic pregnancies at term
  91. Preeclampsia and the cardiovascular system: An update
  92. Placental thickness in the lower uterine segment and invasive placentation: Will the promise live up?
  93. Cardiac output measurements during high-risk caesarean section using electrical bioreactance or arterial wave form analysis: an assessment of agreement
  94. Lower uterine segment placental thickness in women with abnormally invasive placenta
  95. Book: Genetics for obstetricians and gynaecologists
  96. Sensitivity of first-trimester ultrasound in the detection of congenital anomalies in twin pregnancies: population study and systematic review
  97. Mid-pregnancy fetal growth, uteroplacental Doppler indices and maternal demographic characteristics: role in prediction of stillbirth
  98. Mid-pregnancy fetal biometry, uterine artery Doppler indices and maternal demographic characteristics: role in prediction of small-for-gestational-age birth
  99. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis
  100. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
  101. Re: Maternal obesity and excess of fetal growth in pre-eclampsia
  102. Accuracy of Predicting Fetal Loss in Twin Pregnancies Using Gestational Age-Dependent Weight Discordance Cut-Offs: Analysis of the STORK Multiple Pregnancy Cohort
  103. Neonatal Acid-Base Status in Term Fetuses: Mathematical Models Investigating Cerebroplacental Ratio and Birth Weight
  104. Perioperative management and outcomes of aortic surgery during pregnancy
  105. Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio
  106. Ushering in a new dawn in obstetrics and gynecology: the industry of cell-free DNA testing
  107. Fetal growth reference ranges in twin pregnancy: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  108. Cardiovascular Implications in Preeclampsia
  109. Reversible De Novo Left Ventricular Trabeculations in Pregnant Women
  110. Crown–rump length discordance and adverse perinatal outcome in twin pregnancies: systematic review and meta‐analysis
  111. Association between reduced fetal movements at term and first trimester markers of impaired placental development
  112. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia
  113. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis
  114. Ultrasound estimation of birth weight in twin pregnancy: comparison of biometry algorithms in the STORK multiple pregnancy cohort
  115. Widening of the femoral proximal diaphysis-metaphysis angle in fetuses with achondroplasia
  116. Fetal and placental vascular tumors: persistent fetal hyperdynamic status predisposes to poorer long-term neurodevelopmental outcome
  117. Association between reduced fetal movements at term and abnormal uterine artery Doppler indices
  118. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women
  119. Outcome of first-trimester fetal abdominal cysts: cohort study and review of the literature
  120. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term
  121. Multiple pregnancy: Preface
  122. Prenatal prediction of need for ventriculoperitoneal shunt in open spina bifida
  123. Twin pregnancy chorionicity determination in a tertiary care setting
  124. Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis
  125. Second-trimester discordance and adverse perinatal outcome in twins: the STORK multiple pregnancy cohort
  126. Comment on “First trimester uterine artery Doppler velocimetry in the prediction of birth weight in a low-risk population”
  127. Biparietal diameter at 11 to 13 weeks' gestation in fetuses with holoprosencephaly
  128. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial
  129. “Assisted” Reshaping of the Fetal Heart?
  130. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
  131. Biparietal diameter at 11–13 weeks' gestation in fetuses with open spina bifida
  132. Value of adding second-trimester uterine artery Doppler to patient characteristics in identification of nulliparous women at increased risk for pre-eclampsia: an individual patient data meta-analysis
  133. Embryonic growth discordance and early fetal loss: the STORK multiple pregnancy cohort and systematic review
  134. Association between first‐trimester maternal serum pregnancy‐associated plasma protein‐A and obstetric complications
  135. Role of cerebroplacental ratio for fetal assessment in prolonged pregnancy
  136. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis
  137. Crown-rump length discordance and adverse perinatal outcome in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  138. Early fetal loss in monochorionic and dichorionic twin pregnancies: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  139. Weight discordance and perinatal mortality in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  140. Does antenatal ultrasound labeling predict birth order in twin pregnancies?
  141. Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling
  142. Comparison of Wavelet Transform and Time-Domain Analysis of Second Trimester Uterine Artery Doppler Waveforms in Screening for Pre-Eclampsia
  143. Cardiac structure and function in normal pregnancy
  144. Mid‐gestational maternal cardiovascular profile in preterm and term pre‐eclampsia: a prospective study
  145. Elective birth at 37 weeks of gestation versus standard care for women with an uncomplicated twin pregnancy at term: the Twins Timing of Birth Randomised Trial
  146. Counseling in fetal medicine: agenesis of the corpus callosum
  147. The diagnostic and therapeutic role of ultrasound in obstetrics
  148. Severe Myocardial Impairment and Chamber Dysfunction in Preterm Preeclampsia
  149. The effect of the contents of exomphalos and nuchal translucency at 11-14 weeks on the likelihood of associated chromosomal abnormality
  150. Prediction of Preeclampsia by Combining Serum Histidine-Rich Glycoprotein and Uterine Artery Doppler
  151. Neurodevelopmental delay in small babies at term: a systematic review
  152. Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth Restriction
  153. Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance
  154. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies
  155. Corrections
  156. Relationship of first‐trimester uterine artery Doppler to late stillbirth
  157. Prospective risk of late stillbirth in monochorionic twins: a regional cohort study
  158. LEFT VENTRICULAR HYPERTRABECULATION IN AFRO-CARIBBEAN INDIVIDUALS: AN INHERITED CARDIOMYOPATHY OR A PHYSIOLOGICAL RESPONSE TO INCREASED CARDIAC PRELOAD
  159. A perfusion confusion?
  160. Prediction of selective fetal growth restriction and twin-to-twin transfusion syndrome in monochorionic twins
  161. Role of Second-Trimester Uterine Artery Doppler in Assessing Stillbirth Risk
  162. Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation
  163. Is first‐trimester crown–rump length associated with birthweight?
  164. Maternal cardiac function in preeclampsia
  165. Pregnancy Outcome of Monochorionic Twins: Does Amnionicity Matter?
  166. Antibiotic prophylaxis before amniocentesis
  167. The evidence base for miscarriage diagnosis: better late than never
  168. Preeclampsia Is Associated With Persistent Postpartum Cardiovascular Impairment
  169. Antenatal care for twin and triplet pregnancies: summary of NICE guidance
  170. Elevated glucocorticoid metabolism in placental tissue from first trimester pregnancies at increased risk of pre-eclampsia
  171. Systematic labeling of twin pregnancies on ultrasound
  172. Early prediction and prevention of pre-eclampsia
  173. Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia
  174. First‐trimester ultrasound determination of chorionicity in twin pregnancy
  175. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices
  176. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
  177. Prevalence of maternal cardiac defects in women with high‐resistance uterine artery Doppler indices
  178. Prenatal diagnosis of non‐immune hydrops fetalis: what do we tell the parents?
  179. Maternal Cardiac Dysfunction and Remodeling in Women With Preeclampsia at Term
  180. Second‐trimester assessment of gestational age in twins: validation of singleton biometry charts
  181. Early pregnancy growth and pregnancy outcome in twin pregnancies
  182. Late termination of pregnancy and foetal reduction for foetal anomaly
  183. Early-Pregnancy Multiple Serum Markers and Second-Trimester Uterine Artery Doppler in Predicting Preeclampsia
  184. First-trimester ultrasound dating of twin pregnancy: are singleton charts reliable?
  185. Prenatal ultrasound in the prediction of bowel obstruction in infants with gastroschisis
  186. Prenatal findings and differential diagnosis of scimitar syndrome and pulmonary sequestration
  187. Sensitivity of higher, lower and mean second-trimester uterine artery Doppler resistance indices in screening for pre-eclampsia
  188. Giant placental chorioangioma: natural history and pregnancy outcome
  189. Cord entanglement and perinatal outcome in monoamniotic twin pregnancies
  190. The diagnostic and therapeutic role of ultrasound in obstetrics
  191. Guidelines for the management of postterm pregnancy
  192. Raised Maternal Serum Cystatin C: An Early Pregnancy Marker for Preeclampsia
  193. Relationship of intertwin crown-rump length discrepancy to chorionicity, fetal demise and birth-weight discordance
  194. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction
  195. First‐trimester uterine artery Doppler indices in the prediction of small‐for‐gestational age pregnancy and intrauterine growth restriction
  196. Association of Uterine Artery Doppler Resistance Index and Birth Weight: Effect of Customized Birth Weight Standards
  197. First trimester uterine artery Doppler in women with previous pre‐eclampsia
  198. Congenital vascular malformations: A series of five prenatally diagnosed cases
  199. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia
  200. Outcome of Fetuses With Antenatally Diagnosed Short Femur
  201. Predictors of necrotizing enterocolitis in preterm growth-restricted neonates
  202. Outcome of fetuses with antenatally diagnosed short femur
  203. First‐trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine
  204. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin
  205. The prediction of intra-partum fetal compromise in prolonged pregnancy
  206. Ultrasound assessment of cervical length in prolonged pregnancy: prediction of spontaneous onset of labor and successful vaginal delivery
  207. Authors response to: Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  208. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses
  209. Outcome of antenatally diagnosed abdominal wall defects
  210. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
  211. Effect of heparin and fractionated heparin on trophoblast invasion
  212. Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
  213. Influence of parity on fetal mortality in prolonged pregnancy
  214. Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  215. Problem Based Obstetric Ultrasound
  216. MRI of the foetal brain
  217. Outcome of prenatally diagnosed agenesis of the corpus callosum
  218. Posterior fossa malformation in fetuses: a report of 56 further cases and a review of the literature
  219. The role of ultrasound in obstetrics
  220. Predictors of Neonatal Outcome in Early- Onset Placental Dysfunction
  221. First‐trimester uterine artery Doppler and spontaneous preterm delivery
  222. Maternal and neonatal outcome after failed ventouse delivery: Comparison of forceps versus cesarean section
  223. Prenatal diagnosis of segmental spinal dysgenesis
  224. Maternal cardiac function in early pregnancies with high uterine artery resistance
  225. Uterine artery Doppler velocimetry at 11–14 weeks in singleton pregnancies conceived by assisted reproductive technology
  226. Fetal surgical interventions
  227. Influence of parity on first trimester endovascular trophoblast invasion
  228. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  229. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations
  230. Effect of first-trimester serum from pregnant women with high-resistance uterine artery Doppler resistance on extravillous trophoblast invasion
  231. Effect of inter-twin delivery interval on neonatal haemoglobin concentration
  232. Effect of low dose heparin, unfractionated heparin and aspirin on trophoblast invasion
  233. Computerized fetal heart rate analysis (CCTG) for prediction of acidemia in fetal growth restriction (IUGR)
  234. Effect of serum from women with abnormal uterine artery Doppler resistance on extravillous trophoblast invasion in the first trimester
  235. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results
  236. A newly described thoracic vascular malformation in fetuses with Down syndrome
  237. Neonatal outcome of antenatally diagnosed congenital cystic adenomatoid malformations
  238. First-Trimester Ductus Venosus, Nasal Bones, and Down Syndrome in a High-Risk Population
  239. The sensitivity of antenatal ultrasound for predicting renal tract surgery in early childhood
  240. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy
  241. Natural history and outcome of prenatally diagnosed cystic hygroma
  242. Recent advances in the management of placenta previa
  243. Second‐trimester uterine artery Doppler and spontaneous preterm delivery
  244. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies
  245. What prenatal diagnosis should be offered in multiple pregnancy?
  246. The Longitudinal Variation in Uterine Artery Blood Flow Pattern in Relation to Birth Weight
  247. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices
  248. Viability in early-onset IUGR: is it time to reconsider intervention thresholds?
  249. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms
  250. Ultrasound-guided interstitial laser therapy for the treatment of placental chorioangioma
  251. Pre-natal diagnosis: structural anomalies
  252. First‐trimester uterine artery blood flow and birth weight
  253. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia
  254. Association between increased nuchal translucency and second trimester cardiac echogenic foci*1
  255. The role of oxytocin in parturition
  256. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests
  257. Nuchal translucency thickness measurement: repeatability using a virtual ultrasound scanner
  258. Improving the effectiveness of routine prenatal screening for major congenital heart defects
  259. Prospective risk of stillbirth in multiple-gestation pregnancies: a population-based analysis
  260. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  261. Comparison of feticide carried out by cordocentesis versus cardiac puncture
  262. Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population
  263. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  264. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  265. Sensitivity and accuracy of routine antenatal ultrasound screening for isolated facial clefts
  266. Routine ultrasound for the prenatal diagnosis of congenital diaphragmatic hernia: the ‘isms’
  267. Fetal medicine: a liquid frontier
  268. Uterine artery resistance and anxiety in the second trimester of pregnancy
  269. The human ductus venosus between 13 and 17 weeks of gestation: histological and morphometric studies
  270. Reproducibility and repeatability of transabdominal uterine artery Doppler velocimetry between 10 and 14 weeks of gestation
  271. The anatomy of the umbilical, portal and hepatic venous systems in the human fetus at 14-19 weeks of gestation
  272. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency
  273. The role of ultrasound in the expectant management of early pregnancy loss
  274. Fetal anemia as a consequence of hemorrhage into an ovarian cyst
  275. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler
  276. Intraobserver and interobserver variability of transabdominal Doppler velocimetry measurements of the fetal ductus venosus between 10 and 14 weeks of gestation
  277. Role of ultrasound in obstetrics
  278. Natural history of fetal hydronephrosis diagnosed on mid-trimester ultrasound
  279. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects
  280. Increased nuchal translucency and normal karyotype: coping with uncertainty
  281. Antenatal diagnosis of fetal intra‐abdominal umbilical vein dilatation
  282. Sono-endoscopic delineation of the placental vascular equator prior to selective fetoscopic laser ablation in twin-to-twin transfusion syndrome
  283. Twin-to-twin transfusion syndrome - debates on the etiology, natural history and management
  284. Coping with winter bed crises
  285. Effectiveness of prenatal chromosomal analysis using multicolour fluorescent in situ hybridisation
  286. First trimester screening for fetal abnormalities
  287. First trimester nuchal translucency: effective routine screening for Down's syndrome.
  288. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
  289. First‐trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?
  290. Influence of ethnic origin on nuchal translucency screening for Down's syndrome
  291. TRANSFER OF NUCLEATED MATERNAL CELLS INTO FETAL CIRCULATION DURING THE SECOND TRIMESTER OF PREGNANCY
  292. A nude mouse xenograft model to investigate slow cycling edidermal stem cells
  293. Relationship between fetal nuchal translucency thickness and second trimester maternal serum biochemistry
  294. Racial equity of screening for trisomy 21: comparison of nuchal translucency and maternal serum biochemistry
  295. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome
  296. Nuchal translucency: a marker for the antenatal diagnosis of aortic coarctation
  297. Maternal platelet size as a marker for fetal trisomies 18 and 13
  298. Neutrophil and monocyte β2-integrin expression in trisomic fetuses
  299. Blood transferrin receptor expression in chromosomally abnormal fetuses
  300. Neutrophil and monocyte β2-integrin expression in maternal and fetal blood
  301. Labor: An immunologically beneficial process for the neonate
  302. Fetal immunodeficiency: A consequence of placental insufficiency
  303. Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood
  304. Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation
  305. Subpopulations of CD34‐positive haemopoietic progenitors in fetal blood
  306. Umbilical cord blood erythroblast count as an index of intrauterine hypoxia.
  307. Abnormal immunological development in fetuses with trisomy 18
  308. Fetal Blood Mononuclear Cell Division in Normal and Pathological Pregnancies
  309. Maternal Peripheral Blood Lymphocyte Subpopulations in Normal and Pathological Pregnancies
  310. Fetal plasma erythropoietin concentration in red blood cell‐isoimmunized pregnancies
  311. Fetal plasma interferon gamma concentration in normal pregnancy
  312. Abnormal fetal immunological development in Down's syndrome
  313. Fetal B Lymphocyte Subpopulations in Normal Pregnancies
  314. Management of the third stage of labour in women at low risk of postpartum haemorrhage
  315. Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies
  316. Erythroblastosis in birth asphyxia
  317. Fetal and Maternal Erythropoietin Levels in Normal Pregnancy
  318. Cordocentesis in the investigation of fetal erythropoiesis
  319. Erythroblastosis and reticulocytosis in anemic fetuses
  320. Antenatal care for women with pre-existing medical, obstetric or mental health conditions